Related Experiment Video
Updated: Jun 25, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
Non-cystic Fibrosis and Non-tuberculosis Sequela Bronchiectasis
Jaqueline Schaparini Fonini1, Stefan B Watzka2
1Department of Thoracic Surgery, Universidade de São Paulo, São Paulo/SP, Brazil.
Non-cystic fibrosis and non-tuberculous bronchiectasis are increasingly diagnosed due to advanced imaging. Understanding the cause is key for prognosis and tailored medical management, including airway clearance and antibiotics.
Area of Science:
- Pulmonology
- Radiology
Background:
- Non-cystic fibrosis and non-tuberculous bronchiectasis are increasingly recognized.
- Improved imaging, especially high-resolution computed tomography (HRCT), aids diagnosis.
- Disease presentation, severity, and progression are highly variable due to diverse etiologies.
Purpose of the Study:
- To highlight the increasing recognition and diagnostic approaches for bronchiectasis.
- To emphasize the importance of identifying underlying causes for effective management.
- To outline core medical strategies for treating bronchiectasis.
Main Methods:
- Diagnosis relies on high-resolution computed tomography (HRCT) as the gold standard.
- Clinical awareness and improved imaging techniques facilitate earlier detection.
- Etiological investigation is crucial for personalized treatment planning.
Main Results:
- Bronchiectasis presents a heterogeneous clinical picture.
- The underlying cause significantly impacts prognosis and treatment decisions.
- Individualized medical management is essential for optimal outcomes.
Conclusions:
- Early and accurate diagnosis of bronchiectasis is vital.
- Understanding the specific etiology guides prognosis and therapeutic strategies.
- Comprehensive management involves airway clearance, antibiotics, and comorbidity control.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Chronic Obstructive Pulmonary Disease II: Emphysema
Tuberculosis

